GlaxoSmithkline Pharma decides to enter into India-specific alliance

04 Feb 2013 Evaluate

Multinational drug-maker, GlaxoSmithkline Pharmaceuticals has decided to enter into India-specific alliance, which will be for a product that is a new area for the company. With this decision to bring in niche products from other drug-majors through in-licensing deals, the company aims to expand the operations locally.

The entity’s existing alliances in the local market include ones with Daiichi-Sankyo on hypertensive Olmesartan Medoxomil, and with Astellas on anti-fungal drug Micafungin.

Glaxosmithkline Phar Share Price

2308.35 -71.50 (-3.00%)
23-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×